This week Pfizer seeks Emergency Use Authorization for their investigational COVID-19 oral antiviral; A meta-analysis found commonly prescribed drugs were linked to orthostatic hypotension; A novel treatment is approved for polycythemia vera; A new program has been cleared to allow individuals to carry out remote endoscopy procedures; And the largest psilocybin trial to date shows promise in treatment-resistant depression.